Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 361

1.

Medication compliance among patients with bipolar disorder and substance use disorder.

Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML.

J Clin Psychiatry. 1998 Apr;59(4):172-4.

PMID:
9590667
2.

Clinical factors associated with treatment noncompliance in euthymic bipolar patients.

Colom F, Vieta E, Martínez-Arán A, Reinares M, Benabarre A, Gastó C.

J Clin Psychiatry. 2000 Aug;61(8):549-55.

PMID:
10982196
3.

Compliance with maintenance treatment in bipolar disorder.

Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA.

Psychopharmacol Bull. 1997;33(1):87-91.

PMID:
9133756
4.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
5.

Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.

Brady KT, Sonne SC, Anton R, Ballenger JC.

J Clin Psychiatry. 1995 Mar;56(3):118-21.

PMID:
7883730
6.

A history of substance abuse complicates remission from acute mania in bipolar disorder.

Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L.

J Clin Psychiatry. 1999 Nov;60(11):733-40.

PMID:
10584760
7.

Nonadherence with mood stabilizers: prevalence and predictors.

Scott J, Pope M.

J Clin Psychiatry. 2002 May;63(5):384-90.

PMID:
12019661
8.

Divalproex sodium in substance abusers with mood disorder.

Albanese MJ, Clodfelter RC Jr, Khantzian EJ.

J Clin Psychiatry. 2000 Dec;61(12):916-21.

PMID:
11206596
9.

The relationship between substance abuse and bipolar disorder.

Brady KT, Sonne SC.

J Clin Psychiatry. 1995;56 Suppl 3:19-24. Review.

PMID:
7883738
10.

Non-lithium treatment for bipolar disorder.

Post RM.

J Clin Psychiatry. 1990 Aug;51 Suppl:9-16; discussion 17-9. Review.

PMID:
2116406
11.

Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.

State RC, Frye MA, Altshuler LL, Strober M, DeAntonio M, Hwang S, Mintz J.

J Clin Psychiatry. 2004 Aug;65(8):1057-63.

PMID:
15323589
12.
13.

Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.

Kim JH, Choi SW, Joe SH, Ha TH, Yoo HJ, Choi JE, Cha B, Ha K.

Nord J Psychiatry. 2008;62(6):496-502. doi: 10.1080/08039480801985229.

PMID:
18841509
14.

Long-term use of valproate in primary psychiatric disorders.

Hayes SG.

J Clin Psychiatry. 1989 Mar;50 Suppl:35-9.

PMID:
2494158
15.

Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?

Kleindienst N, Greil W.

J Clin Psychiatry. 2004 Jul;65(7):966-74.

PMID:
15291686
16.

Predictors of response to divalproex and lithium.

Bowden CL.

J Clin Psychiatry. 1995;56 Suppl 3:25-30. Review.

PMID:
7883739
17.

Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.

Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.

Hum Psychopharmacol. 2002 Oct;17(7):321-7.

PMID:
12415549
18.

Psychiatric and medical comorbidities of bipolar disorder.

Krishnan KR.

Psychosom Med. 2005 Jan-Feb;67(1):1-8. Review.

PMID:
15673617
19.

Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine?

Gerner RH, Stanton A.

J Clin Psychopharmacol. 1992 Feb;12(1 Suppl):57S-63S.

PMID:
1541719
20.

Dysphoric mania.

Clothier J, Swann AC, Freeman T.

J Clin Psychopharmacol. 1992 Feb;12(1 Suppl):13S-16S.

PMID:
1541712

Supplemental Content

Support Center